Published in Clin Orthop Relat Res on October 01, 1999
Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature (2013) 1.33
Identification of a stem cell niche in the zone of Ranvier within the knee joint. J Anat (2009) 1.09
Synovial chondromatosis: the possible role of FGF 9 and FGF receptor 3 in its pathology. Int J Exp Pathol (2000) 1.08
Fibroblast growth factor signaling in skeletal development and disease. Genes Dev (2015) 1.04
Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells. Br J Cancer (2009) 0.98
The perichondrial ring as a reservoir for precartilaginous cells. In vivo model in young chicks' epiphysis. Int Orthop (2006) 0.87
Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation. Osteoarthritis Cartilage (2014) 0.84
Achondroplasia: Development, Pathogenesis, and Therapy. Dev Dyn (2016) 0.83
PTHrP, PTHr, and FGFR3 are involved in the process of endochondral ossification in human osteophytes. Histochem Cell Biol (2003) 0.82
Transforming growth factor-β1 (TGF-β1) induces mouse precartilaginous stem cell proliferation through TGF-β receptor II (TGFRII)-Akt-β-catenin signaling. Int J Mol Sci (2014) 0.78
Vascularization of primary and secondary ossification centres in the human growth plate. BMC Dev Biol (2014) 0.77
Differentiation of immortalized human precartilaginous stem cells into nucleus pulposus-like cells. Int J Clin Exp Pathol (2015) 0.75
Use of a novel joint-simulating culture system to grow organized ex-vivo three-dimensional cartilage-like constructs from embryonic epiphyseal cells. Iowa Orthop J (2005) 0.75
Chondrogenic effect of cell-based scaffold of self-assembling peptides/PLGA-PLL loading the hTGFβ3 plasmid DNA. J Mater Sci Mater Med (2015) 0.75
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell (2000) 5.72
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol (1992) 3.41
Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A (1985) 3.31
Smoking, health, and survival: prospects in Bangladesh. Lancet (1981) 3.05
Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol (1993) 2.96
Factors controlling amino acid incorporation by ribosomes from krebs II mouse ascites-tumour cells. Biochem J (1966) 2.77
The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet (2001) 2.71
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59
Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet (1995) 2.57
Amphibian declines: an immunological perspective. Dev Comp Immunol (1999) 2.41
Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet (1995) 2.29
Assessment of sternal vascularity with single photon emission computed tomography after harvesting of the internal thoracic artery. J Thorac Cardiovasc Surg (1999) 2.24
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell (1994) 2.23
Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development (1991) 2.16
Treatment of staphylococcal septic arthritis in rabbits by systemic antibiotics and intra-articular corticosteroids. Ann Rheum Dis (1998) 2.15
Prevalence and determinants of nutritional blindness in Bangladeshi children. World Health Stat Q (1985) 2.12
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci U S A (1996) 2.12
Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J (1984) 2.11
Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness. Diabetologia (1994) 2.03
Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J (1992) 2.00
Behaviorally conditioned immunosuppression. Psychosom Med (1975) 1.97
Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology (2012) 1.92
ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J Biol Chem (1994) 1.88
A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci U S A (1999) 1.75
Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J Protozool (1983) 1.70
The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat Genet (1999) 1.69
Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc Natl Acad Sci U S A (1985) 1.62
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet (1999) 1.62
Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest (1999) 1.62
Regulation of cellular infiltration into tissue engineering scaffolds composed of submicron diameter fibrils produced by electrospinning. Acta Biomater (2005) 1.60
The effect of social desirability trait on self-reported dietary measures among multi-ethnic female health center employees. Ann Epidemiol (2001) 1.60
Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. Am J Cardiol (1979) 1.58
Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin. Nat Genet (2001) 1.53
Stimulation of chondromucoprotein synthesis in chondrocytes by extracellular chondromucoprotein. Proc Natl Acad Sci U S A (1972) 1.50
Hypertension and a tumor of the glomus jugulare region. Evidence for epinephrine biosynthesis. Am J Hypertens (1993) 1.47
Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J Protozool (1984) 1.46
Increasing fruit and vegetable consumption through worksites and families in the treatwell 5-a-day study. Am J Public Health (1999) 1.43
Physician use of a computerized medical record system during the patient encounter: a descriptive study. Comput Methods Programs Biomed (1994) 1.41
Current status of whole-body counting as a means to detect and quantify previous exposures to radioactive materials. Whole-body Counting Working Group. Health Phys (1991) 1.39
Autologous chondrocyte transplantation for reconstruction of isolated joint defects: the Assaf Harofeh experience. Isr Med Assoc J (2000) 1.39
The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol (2000) 1.38
Baseline fruit and vegetable intake among adults in seven 5 a day study centers located in diverse geographic areas. J Am Diet Assoc (1999) 1.38
Presentation of marital problems in general practice. Practitioner (1984) 1.38
Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency. Nat Genet (1998) 1.38
Synthesis of chondromucoprotein by chondrocytes in suspension culture. Dev Biol (1972) 1.35
Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol (1993) 1.34
High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature (1992) 1.34
"Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med (1987) 1.28
Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol (1990) 1.26
Prevalence of antibodies to Rochalimaea species (cat-scratch disease agent) in cats. Vet Rec (1995) 1.26
Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites. J Am Soc Nephrol (1998) 1.22
Total syntheses of optically active 19-norsteroids. (+)-Estr-4-ene-3,17-dione and (+)13 beta-ethylgon-4-ene-3,17-dione. J Org Chem (1975) 1.20
Fewer residents: financial, educational, and practical implications. Anesth Analg (1998) 1.19
HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells. Tissue Antigens (1982) 1.19
Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Hum Gene Ther (1998) 1.19
The juvenile baboon as a model for studies of lead poisoning in children. J Med Primatol (1972) 1.19
Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem (1994) 1.18
Carcinoma of the thyroglossal duct. Am J Surg (1983) 1.17
How much can we expect from vasodilator therapy in congestive heart failure? Circulation (1979) 1.17
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B. Am J Hum Genet (1999) 1.15
Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem (1994) 1.15
FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation. FEBS Lett (2002) 1.14
The Drosophila Ras2 and Rop gene pair: a dual homology with a yeast Ras-like gene and a suppressor of its loss-of-function phenotype. Development (1993) 1.14
The differential impact of training stress and final examination stress on herpesvirus latency at the United States Military Academy at West Point. Brain Behav Immun (1999) 1.13
Moyamoya and Fanconi's anemia. Pediatrics (1980) 1.13
Two distinct immunoglobulin heavy chain isotypes in a primitive, cartilaginous fish, Raja erinacea. Nucleic Acids Res (1990) 1.13
Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved. J Immunol (1999) 1.12
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I. J Pharm Biomed Anal (2004) 1.12
Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res (1998) 1.12
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 1.11
Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70. Eur J Immunol (2001) 1.11
Immune responses of thymus/lymphocyte embryonic chimeras: studies on tolerance and major histocompatibility complex restriction in Xenopus. Eur J Immunol (1985) 1.10
Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc Natl Acad Sci U S A (1994) 1.09
Atrichia with papular lesions resulting from a nonsense mutation within the human hairless gene. J Invest Dermatol (1999) 1.08
Synovial chondromatosis: the possible role of FGF 9 and FGF receptor 3 in its pathology. Int J Exp Pathol (2000) 1.08
Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol (1977) 1.08
Changes in proteoglycans of intervertebral disc in diabetic patients. A possible cause of increased back pain. Spine (Phila Pa 1976) (1998) 1.07
Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice. J Bone Miner Res (1999) 1.06
Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science (1982) 1.05
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part II. J Pharm Biomed Anal (2007) 1.04
Use of hydroxyapatite in spine surgery. Eur Spine J (2001) 1.03
Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene (1997) 1.03
Immunoglobulin heavy chain gene organization and complexity in the skate, Raja erinacea. Nucleic Acids Res (1990) 1.03
Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. Am J Hum Genet (1997) 1.03
Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum Mol Genet (2000) 1.03
Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. Biochemistry (1997) 1.03
Evaluation framework for carotid bifurcation lumen segmentation and stenosis grading. Med Image Anal (2011) 1.03
Worksite and family education for dietary change: the Treatwell 5-a-Day program. Health Educ Res (1998) 1.02
Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol Cell Biol (1997) 1.01
T2 mapping and dGEMRIC after autologous chondrocyte implantation with a fibrin-based scaffold in the knee: preliminary results. Eur J Radiol (2009) 1.01
A single sample subcutaneous luteinizing hormone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists. J Clin Endocrinol Metab (1999) 1.01
Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. J Clin Invest (1999) 1.00
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part III. J Pharm Biomed Anal (2007) 0.99
HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics (1986) 0.99
Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor. J Cell Biochem (1995) 0.99
Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucine into Plasmodium falciparum in vitro. J Protozool (1984) 0.98